BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10792025)

  • 1. Critical contribution of liver natural killer T cells to a murine model of hepatitis.
    Takeda K; Hayakawa Y; Van Kaer L; Matsuda H; Yagita H; Okumura K
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5498-503. PubMed ID: 10792025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
    Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
    Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice.
    Adachi K; Tsutsui H; Seki E; Nakano H; Takeda K; Okumura K; Van Kaer L; Nakanishi K
    Int Immunol; 2004 Jun; 16(6):787-98. PubMed ID: 15096477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice.
    Huang W; Dong Z; Wei H; Ding C; Sun R; Tian Z
    Liver Int; 2006 Apr; 26(3):339-45. PubMed ID: 16584397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis.
    Iwata A; Watanabe N; Oya Y; Owada T; Ikeda K; Suto A; Kagami S; Hirose K; Kanari H; Kawashima S; Nakayama T; Taniguchi M; Iwamoto I; Nakajima H
    J Immunol; 2010 Jan; 184(1):127-33. PubMed ID: 19949073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T-cells participate in rejection of islet allografts in the liver of mice.
    Toyofuku A; Yasunami Y; Nabeyama K; Nakano M; Satoh M; Matsuoka N; Ono J; Nakayama T; Taniguchi M; Tanaka M; Ikeda S
    Diabetes; 2006 Jan; 55(1):34-9. PubMed ID: 16380474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.
    Jiang W; Sun R; Zhou R; Wei H; Tian Z
    J Immunol; 2009 Mar; 182(6):3768-74. PubMed ID: 19265155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
    Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
    Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus.
    Broxmeyer HE; Dent A; Cooper S; Hangoc G; Wang ZY; Du W; Gervay-Haque J; Sriram V; Renukaradhya GJ; Brutkiewicz RR
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):87-93. PubMed ID: 17379092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes.
    Tagawa Y; Sekikawa K; Iwakura Y
    J Immunol; 1997 Aug; 159(3):1418-28. PubMed ID: 9233639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis.
    Lalazar G; Ben Ya'acov A; Lador A; Livovsky DM; Pappo O; Preston S; Hareati M; Ilan Y
    Mol Immunol; 2008 Aug; 45(13):3517-25. PubMed ID: 18572246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Con A-induced hepatitis induction in ICOS-deficient mice.
    Watanabe S; Ohnuki K; Hara Y; Ishida Y; Ikarashi Y; Ogawa S; Kishimoto H; Tanabe K; Abe R
    Immunol Lett; 2010 Jan; 128(1):51-8. PubMed ID: 19914290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
    Xu X; Wei H; Dong Z; Chen Y; Tian Z
    Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.